Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Trials

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Pipeline

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

9,577 stories indexed, page 143 of 160

🇯🇵Jan 1, 1970CDMOchugai-pharm.co.jp

Featured signal

Roche’s Announcement Regarding New Data of Enspryng for Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)

Publisher

Chugai Pharmaceutical

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

Chugai PharmaceuticalOriginal publisher link

Canonical metadata stays public, while full text remains on the original site.

🇯🇵Jan 1, 1970CDMOchugai-pharm.co.jp

Apr 10,2026 | Chugai Selected as “Digital Transformation Stocks (DX Stocks) 2026” | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source

🇯🇵Jan 1, 1970CDMOchugai-pharm.co.jp

Announcement of Termination of Co-Promotion of Rituxan ® in Japan (Anti-CD20 Monoclonal Antibody)

Chugai PharmaceuticalOriginal source

🇯🇵Jan 1, 1970CDMOchugai-pharm.co.jp

Apr 06,2026 | Research Results on Immune Thrombocytopenia from a Joint Study with Osaka University’s IFReC Published in Blood | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source

🇯🇵Jan 1, 1970CDMOchugai-pharm.co.jp

Lilly’s Announcement Regarding Oral GLP-1 Foundayo™ (Orforglipron)

Chugai PharmaceuticalOriginal source

🇩🇪Jan 1, 1970Researchcharite.de

RSS Feed: Charité – Universitätsmedizin Berlin

Charité – Universitätsmedizin BerlinOriginal source

🇩🇪Jan 1, 1970Researchcharite.de

Leichte Sprache: Charité – Universitätsmedizin Berlin

Charité – Universitätsmedizin BerlinOriginal source

🇩🇪Jan 1, 1970Researchcharite.de

Alle Kliniken/Zentren anzeigen

Charité – Universitätsmedizin BerlinOriginal source

🇩🇪Jan 1, 1970Researchcharite.de

51: 01-2 ClinicExpertFinder: Charité – Universitätsmedizin Berlin

Charité – Universitätsmedizin BerlinOriginal source

🇩🇪Jan 1, 1970Researchcharite.de

Teaching & Learning: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Press reports: Charité – Universitätsmedizin Berlin

Charité – Universitätsmedizin BerlinOriginal source

🇩🇪Jan 1, 1970Researchcharite.de

51: 01-2 ClinicExpertFinder: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Display all Departments / Centers

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Fifteen Charité researchers among the top influencers in science: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Research: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

International: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Deutsches Herzzentrum der Charité (DHZC): Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Emergency medicine / Central emergency rooms: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Information for patients and families: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Book appointments: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Clinical Center: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Campus Virchow-Klinikum (CVK)

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Campus Charité Mitte: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Campus Berlin Buch: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Campus Benjamin Franklin (CBF): Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Charité: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Berlin Institute of Health: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Neues aus der Charité: Charité – Universitätsmedizin Berlin

Charité (Full Press Center)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Navi App: Charité – Universitätsmedizin Berlin

Charité (Full Press Center)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Campus Charité Mitte: Charité – Universitätsmedizin Berlin

Charité (Full Press Center)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Campus Berlin Buch: Charité – Universitätsmedizin Berlin

Charité (Full Press Center)Original source

🇩🇪Jan 1, 1970Researchcharite.de

Campus Benjamin Franklin: Charité – Universitätsmedizin Berlin

Charité (Full Press Center)Original source

🇺🇸Jan 1, 1970Industrycencora.com

Heather Zenk - Supply Chain innovation | Cencora

Cencora (formerly AmerisourceBergen)Original source

🇺🇸Jan 1, 1970Industrycencora.com

Driving successful pharma supply chain solutions | Cencora

Cencora (formerly AmerisourceBergen)Original source

🇺🇸Jan 1, 1970Industrycencora.com

Thoughtspot 2025 | Cencora

Cencora (formerly AmerisourceBergen)Original source

🇺🇸Jan 1, 1970Industrycencora.com

FDA 12-digit NDC format | Cencora

Cencora (formerly AmerisourceBergen)Original source

🇺🇸Jan 1, 1970Industrycencora.com

Matt Sample on DSCSA Developments 2026 | Cencora

Cencora (formerly AmerisourceBergen)Original source

🇺🇸Jan 1, 1970Industrycencora.com

US distribution of Kite CAR T-cell therapies | Cencora

Cencora (formerly AmerisourceBergen)Original source

🇺🇸Jan 1, 1970Industrycencora.com

Cencora leaders share insights at Asembia AXS26 | Cencora

Cencora (formerly AmerisourceBergen)Original source

🇺🇸Jan 1, 1970Industrycencora.com

Cencora Launches Next-Generation Nucleus Solution | Cencora

Cencora (formerly AmerisourceBergen)Original source

🇫🇷Jan 1, 1970Industrycellectis.com

Press | Cellectis

Cellectis (Global)Original source

🇫🇷Jan 1, 1970Industrycellectis.com

Press | Cellectis

CellectisOriginal source

🇫🇷Jan 1, 1970Industrycellectis.com

13 Apr 2026 04:30 E.S.T. Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform Read more

Cellectis (Global)Original source

🇫🇷Jan 1, 1970Industrycellectis.com

Cellectis to Report First Quarter Financial Results on May 11, 2026 | Cellectis

Cellectis (Global)Original source

🇫🇷Jan 1, 1970Industrycellectis.com

12 May 2026 09:30 E.S.T. Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress Read more

Cellectis (Global)Original source

🇫🇷Jan 1, 1970Industrycellectis.com

Cellectis Reports Results from Shareholders Meeting Held on June 25, 2026 | Cellectis

Cellectis (Global)Original source

🇫🇷Jan 1, 1970Industrycellectis.com

Cellectis Reports Full Year 2025 Financial Results and Provides a Business Update | Cellectis

Cellectis (Global)Original source

🇫🇷Jan 1, 1970Industrycellectis.com

Cellectis Reports Financial Results for the First Quarter 2026 | Cellectis

Cellectis (Global)Original source

🇫🇷Jan 1, 1970Industrycellectis.com

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL | Cellectis

Cellectis (Global)Original source

🇫🇷Jan 1, 1970Industrycellectis.com

Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress | Cellectis

Cellectis (Global)Original source

🇫🇷Jan 1, 1970Industrycellectis.com

Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting | Cellectis

Cellectis (Global)Original source

🇫🇷Jan 1, 1970Industrycellectis.com

Cellectis’ Annual Shareholders General Meeting to be Held on June 25, 2026 | Cellectis

Cellectis (Global)Original source

🇳🇱Jan 1, 1970CDMOcastoredc.com

HealthVerity and Castor launch partnership to seamlessly incorporate real-world data throughout the clinical trial lifecycle

Castor EDCOriginal source

🇳🇱Jan 1, 1970CDMOcastoredc.com

Castor adds nearly 10 commercial Phase II/III eCOA studies in H2 2025

Castor EDCOriginal source

🇳🇱Jan 1, 1970CDMOcastoredc.com

Castor Steps Up to Preserve Critical Research Amid NIH Funding Cuts

Castor EDCOriginal source

🇳🇱Jan 1, 1970CDMOcastoredc.com

Castor Supports LLS in Study to Improve Blood Testing

Castor EDCOriginal source

🇳🇱Jan 1, 1970CDMOcastoredc.com

Castor Launches "Castor for Impact Program" to Advance Health Equity in Clinical Research

Castor EDCOriginal source

🇳🇱Jan 1, 1970CDMOcastoredc.com

Castor Joins C-Path eCOA Consortium, Surpassing 300 Industry Study Milestone

Castor EDCOriginal source

🇳🇱Jan 1, 1970CDMOcastoredc.com

Castor Introduces Castor CoPilot, A Novel AI Solution for Clinical Trials

Castor EDCOriginal source

🇳🇱Jan 1, 1970CDMOcastoredc.com

Castor Catalyst: Launching Self-Driving Clinical Trials with Google Cloud AI

Castor EDCOriginal source